{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:08:10Z","timestamp":1793142490623,"version":"4.5.0"},"reference-count":101,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    Cancer is a global health problem that is often successfully addressed by therapy, with cancer survivors increasing in numbers and living longer world around. Although new cancer treatment options are continuously explored, platinum based chemotherapy agents remain in use due to their efficiency and availability. Unfortunately, all cancer therapies affect normal tissues as well as cancer, and more than 40 specific side effects of platinum based drugs documented so far decrease the quality of life of cancer survivors. Chemotherapy-induced peripheral neuropathy is a frequent side effects of platinum-based chemotherapy agents. This cluster of complications is often so debilitating that patients occasionally have to discontinue the therapy. Sensory neurons of dorsal root ganglia are at the core of chemotherapy-induced peripheral neuropathy symptoms. In these postmitotic cells, DNA damage caused by platinum chemotherapy interferes with normal functioning. Accumulation of DNA-platinum adducts correlates with neurotoxic severity and development of sensation of pain. While biochemistry of DNA-platinum adducts is the same in all cell types, molecular mechanisms affected by DNA-platinum adducts are different in cancer cells and non-dividing cells. This review aims to raise awareness about platinum associated chemotherapy-induced peripheral neuropathy as a medical problem that has remained unexplained for decades. We emphasize the complexity of this condition both from clinical and mechanistical point of view and focus on recent findings about chemotherapy-induced peripheral neuropathy in\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                    model systems. Finally, we summarize current perspectives about clinical approaches for chemotherapy-induced peripheral neuropathy treatment.\n                  <\/jats:p>","DOI":"10.4103\/1673-5374.276321","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T08:13:59Z","timestamp":1582877639000},"page":"1623-1630","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Insights into platinum-induced peripheral neuropathy\u2013current perspective"],"prefix":"10.4103","volume":"15","author":[{"given":"Andrijana","family":"Lazi\u0107","sequence":"first","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Popovi\u0107","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Department of Radiation Oncology, Northwestern University, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Paunesku","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Department of Radiation Oncology, Northwestern University, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle E.","family":"Woloschak","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Department of Radiation Oncology, Northwestern University, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-7334","authenticated-orcid":false,"given":"Milena","family":"Stevanovi\u0107","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia"},{"name":"Faculty of Biology, University of Belgrade, Belgrade, Serbia"},{"name":"Serbian Academy of Sciences and Arts, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"R1-20260525","first-page":"Cd005228","article-title":"Interventions for preventing neuropathy caused by cisplatin and related compounds","volume":"1","author":"Albers","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20260525","first-page":"CD005228","article-title":"Interventions for preventing neuropathy caused by cisplatin and related compounds","volume":"3","author":"Albers","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-20260525","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/1871520611313020016","article-title":"Platinum compounds: a hope for future cancer chemotherapy","volume":"13","author":"Ali","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"R4-20260525","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2014.02.020","article-title":"Low-doses of cisplatin injure hippocampal synapses: a mechanism for \u2018chemo\u2019 brain","volume":"255","author":"Andres","year":"2014","journal-title":"Exp Neurol"},{"key":"R5-20260525","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","article-title":"Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy","volume":"2","author":"Areti","year":"2014","journal-title":"Redox Biol"},{"key":"R6-20260525","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.nurt.2009.07.003","article-title":"Animal models of chemotherapy-evoked painful peripheral neuropathies","volume":"6","author":"Authier","year":"2009","journal-title":"Neurotherapeutics"},{"key":"R7-20260525","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2018.00104","article-title":"From the bottom-up: chemotherapy and gut-brain axis dysregulation","volume":"12","author":"Bajic","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"R8-20260525","first-page":"18","article-title":"Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies","volume":"70","author":"Beijers","year":"2012","journal-title":"Neth J Med"},{"key":"R9-20260525","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2217\/pmt.15.19","article-title":"Mechanisms involved in the development of chemotherapy-induced neuropathy","volume":"5","author":"Boyette-Davis","year":"2015","journal-title":"Pain Manag"},{"key":"R10-20260525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ilar\/ilt045","article-title":"Institutional animal care and use committee considerations for animal models of peripheral neuropathy","volume":"54","author":"Brabb","year":"2014","journal-title":"ILAR J"},{"key":"R11-20260525","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/toxics3020198","article-title":"Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN)","volume":"3","author":"Canta","year":"2015","journal-title":"Toxics"},{"key":"R12-20260525","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","article-title":"Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?","volume":"596","author":"Carozzi","year":"2015","journal-title":"Neurosci Lett"},{"key":"R13-20260525","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2174\/156800910793605820","article-title":"The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity","volume":"10","author":"Carozzi","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"R14-20260525","first-page":"483","article-title":"Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity","volume":"34","author":"Cavaletti","year":"2014","journal-title":"Anticancer Res"},{"key":"R15-20260525","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nbt.2249","article-title":"Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat Biotechnol"},{"key":"R16-20260525","first-page":"3729","article-title":"Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview","volume":"27","author":"Chan","year":"2019","journal-title":"Support Care Cancer"},{"key":"R17-20260525","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2174\/1566524013666131111125515","article-title":"Platinum-based agents for individualized cancer treatment","volume":"13","author":"Chen","year":"2013","journal-title":"Curr Mol Med"},{"key":"R18-20260525","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/toxics3030304","article-title":"Current view in platinum drug mechanisms of peripheral neurotoxicity","volume":"3","author":"Chiorazzi","year":"2015","journal-title":"Toxics"},{"key":"R19-20260525","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cpt.590","article-title":"Genetic advances uncover mechanisms of chemotherapy-induced peripheral neuropathy","volume":"101","author":"Chua","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"R20-20260525","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/j.pain.0000000000001540","article-title":"Chemotherapy-induced peripheral neuropathy: where are we now","volume":"160","author":"Colvin","year":"2019","journal-title":"Pain"},{"key":"R21-20260525","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncologist"},{"key":"R22-20260525","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/neuonc\/nou048","article-title":"Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin","volume":"16","author":"Deuis","year":"2014","journal-title":"Neuro Oncol"},{"key":"R23-20260525","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.116.236182","article-title":"Palmitoylethanolamide reverses paclitaxel-induced allodynia in mice","volume":"359","author":"Donvito","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"R24-20260525","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/0001-3765201520140352","article-title":"The overexpression of SOX2 affects the migration of human teratocarcinoma cell line NT2\/D1","volume":"87","author":"Drakulic","year":"2015","journal-title":"An Acad Bras Cienc"},{"key":"R25-20260525","first-page":"8671832","article-title":", Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB (2018) Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors","author":"Fung","year":"2018","journal-title":"Adv Urol"},{"key":"R26-20260525","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1007\/s00216-018-1328-8","article-title":"Critical assessment of different methods for quantitative measurement of metallodrug-protein associations","volume":"410","author":"Galvez","year":"2018","journal-title":"Anal Bioanal Chem"},{"key":"R27-20260525","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI1130","article-title":"Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle","volume":"101","author":"Gill","year":"1998","journal-title":"J Clin Invest"},{"key":"R28-20260525","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2013.12.013","article-title":"Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease","volume":"2","author":"Giordano","year":"2014","journal-title":"Redox Biol"},{"key":"R29-20260525","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/0284186X.2017.1398836","article-title":"Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx\u00ae): a placebo-controlled randomised phase II study (PLIANT)","volume":"57","author":"Glimelius","year":"2018","journal-title":"Acta Oncol"},{"key":"R30-20260525","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/1096-9861(20000703)422:3<380::AID-CNE5>3.0.CO;2-C","article-title":"Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro","volume":"422","author":"Guillemain","year":"2000","journal-title":"J Comp Neurol"},{"key":"R31-20260525","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1744-8069-10-56","article-title":"Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status","volume":"10","author":"Guindon","year":"2014","journal-title":"Mol Pain"},{"key":"R32-20260525","first-page":"1223","article-title":"Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Guo","year":"2014","journal-title":"Support Care Cancer"},{"key":"R33-20260525","doi-asserted-by":"crossref","first-page":"1630709","DOI":"10.1155\/2018\/1630709","article-title":"Gaps in understanding mechanism and lack of treatments: potential use of a nonhuman primate model of oxaliplatin-induced neuropathic pain","volume":"2018","author":"Hama","year":"2018","journal-title":"Pain Res Manag"},{"key":"R34-20260525","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fphar.2013.00156","article-title":"Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)","volume":"4","author":"Han","year":"2013","journal-title":"Front Pharmacol"},{"key":"R35-20260525","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pneurobio.2008.04.005","article-title":"Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke","volume":"85","author":"Hara","year":"2008","journal-title":"Prog Neurobiol"},{"key":"R36-20260525","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1039\/c3mt20251h","article-title":"In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS","volume":"5","author":"Hermann","year":"2013","journal-title":"Metallomics"},{"key":"R37-20260525","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ilar\/ilt053","article-title":"Rodent models of chemotherapy-induced peripheral neuropathy","volume":"54","author":"Hoke","year":"2014","journal-title":"ILAR J"},{"key":"R38-20260525","first-page":"571","article-title":"Treatment of chemotherapy-induced peripheral neuropathy: systematic review and recommendations","volume":"21","author":"Hou","year":"2018","journal-title":"Pain Physician"},{"key":"R39-20260525","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/026119291504300105","article-title":"Human embryonal carcinoma cells in serum-free conditions as an in vitro model system of neural differentiation","volume":"43","author":"Jasnic-Savovic","year":"2015","journal-title":"Altern Lab Anim"},{"key":"R40-20260525","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-4-10","article-title":"Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies","volume":"4","author":"Jimenez-Andrade","year":"2008","journal-title":"Mol Pain"},{"key":"R41-20260525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5306\/wjco.v8.i4.329","article-title":"Platinum-induced neurotoxicity: A review of possible mechanisms","volume":"8","author":"Kanat","year":"2017","journal-title":"World J Clin Oncol"},{"key":"R42-20260525","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.tranon.2017.04.012","article-title":"Mangafodipir a selective cytoprotectant - with special reference to oxaliplatin and its association to chemotherapy-induced peripheral neuropathy (CIPN)","volume":"10","author":"Karlsson","year":"2017","journal-title":"Transl Oncol"},{"key":"R43-20260525","doi-asserted-by":"crossref","first-page":"e106485","DOI":"10.1371\/journal.pone.0106485","article-title":"Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy","volume":"9","author":"Kelley","year":"2014","journal-title":"PLoS One"},{"key":"R44-20260525","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.116.235283","article-title":"Identification and characterization of new chemical entities targeting apurinic\/apyrimidinic endonuclease 1 for the prevention of chemotherapy-induced peripheral neuropathy","volume":"359","author":"Kelley","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"R45-20260525","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2017.00086","article-title":"Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review","volume":"8","author":"Kerckhove","year":"2017","journal-title":"Front Pharmacol"},{"key":"R46-20260525","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1134\/S0006297914110042","article-title":"SOX2 overexpression affects neural differentiation of human pluripotent NT2\/D1 cells","volume":"79","author":"Klajn","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"R47-20260525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.12.006","article-title":"Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy","volume":"73","author":"Lees","year":"2017","journal-title":"Eur J Cancer"},{"key":"R48-20260525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2018.10.018","article-title":"Primary cultures from rat dorsal root ganglia: responses of neurons and glial cells to somatosensory or inflammatory stimulation","volume":"394","author":"Leisengang","year":"2018","journal-title":"Neuroscience"},{"key":"R49-20260525","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2016.11.003","article-title":"Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons","volume":"288","author":"Leo","year":"2017","journal-title":"Exp Neurol"},{"key":"R50-20260525","doi-asserted-by":"crossref","first-page":"1744806917746565","DOI":"10.1177\/1744806917746565","article-title":"Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons","volume":"13","author":"Leo","year":"2017","journal-title":"Mol Pain"},{"key":"R51-20260525","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3344\/kjp.2015.28.4.236","article-title":"A new rat model of cisplatin-induced neuropathic pain","volume":"28","author":"Lin","year":"2015","journal-title":"Korean J Pain"},{"key":"R52-20260525","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2016.11.046","article-title":"Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats","volume":"102","author":"Lomeli","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"R53-20260525","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdg301","article-title":"Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients","volume":"14","author":"Lorusso","year":"2003","journal-title":"Ann Oncol"},{"key":"R54-20260525","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/cncr.31248","article-title":"Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: targeting the source","volume":"124","author":"Ma","year":"2018","journal-title":"Cancer"},{"key":"R55-20260525","first-page":"1020","article-title":"New practical approaches to chemotherapy- induced neuropathic pain: prevention, assessment, and treatment","volume":"30","author":"Majithia","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"R56-20260525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092287","article-title":"Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton","author":"Malacrida","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R57-20260525","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"R58-20260525","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.expneurol.2008.08.013","article-title":"Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy","volume":"214","author":"Melli","year":"2008","journal-title":"Exp Neurol"},{"key":"R59-20260525","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","article-title":"Chemotherapy-induced neuropathy: A comprehensive survey","volume":"40","author":"Miltenburg","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"R60-20260525","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s002800050391","article-title":"Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor","volume":"37","author":"Nakagawa","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"R61-20260525","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/bph.14339","article-title":"PPARs and pain","volume":"176","author":"Okine","year":"2019","journal-title":"Br J Pharmacol"},{"key":"R62-20260525","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans"},{"key":"R63-20260525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpain.2016.10.020","article-title":"AAPT diagnostic criteria for chronic cancer pain conditions","volume":"18","author":"Paice","year":"2017","journal-title":"J Pain"},{"key":"R64-20260525","doi-asserted-by":"crossref","first-page":"e70473","DOI":"10.1371\/journal.pone.0070473","article-title":"Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking","volume":"8","author":"Palm-Espling","year":"2013","journal-title":"PLoS One"},{"key":"R65-20260525","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1111\/bph.12645","article-title":"Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain","volume":"171","author":"Percie du Sert","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R66-20260525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2146\/ajhp130126","article-title":"Prevention and treatment of chemotherapy-induced peripheral neuropathy","volume":"71","author":"Piccolo","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"R67-20260525","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.nbd.2010.11.017","article-title":"Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons","volume":"41","author":"Podratz","year":"2011","journal-title":"Neurobiol Dis"},{"key":"R68-20260525","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.nbd.2016.10.003","article-title":"Cisplatin induces mitochondrial deficits in Drosophila larval segmental nerve","volume":"97","author":"Podratz","year":"2017","journal-title":"Neurobiol Dis"},{"key":"R69-20260525","doi-asserted-by":"crossref","first-page":"e91852","DOI":"10.1371\/journal.pone.0091852","article-title":"Expression analysis of SOX14 during retinoic acid induced neural differentiation of embryonal carcinoma cells and assessment of the effect of its ectopic expression on SOXB members in HeLa cells","volume":"9","author":"Popovic","year":"2014","journal-title":"PLoS One"},{"key":"R70-20260525","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10571-019-00667-7","article-title":"Neuroprotective role of selected antioxidant agents in preventing cisplatin-induced damage of human neurons in vitro","volume":"39","author":"Popovic","year":"2019","journal-title":"Cell Mol Neurobiol"},{"key":"R71-20260525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2018.07.026","article-title":"Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin","volume":"140","author":"Poupon","year":"2018","journal-title":"Neuropharmacology"},{"key":"R72-20260525","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/jcb.25103","article-title":"Base excision repair in the mitochondria","volume":"116","author":"Prakash","year":"2015","journal-title":"J Cell Biochem"},{"key":"R73-20260525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mehy.2019.03.031","article-title":"Removal of DNA adducts","volume":"127","author":"Puri","year":"2019","journal-title":"Med Hypotheses"},{"key":"R74-20260525","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1523\/JNEUROSCI.3890-15.2016","article-title":"Mutations in cockayne syndrome-associated genes (Csa and Csb) predispose to cisplatin-induced hearing loss in mice","volume":"36","author":"Rainey","year":"2016","journal-title":"J Neurosci"},{"key":"R75-20260525","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1744-8069-7-29","article-title":"Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice","volume":"7","author":"Renn","year":"2011","journal-title":"Mol Pain"},{"key":"R76-20260525","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.3425","article-title":"Opportunities and challenges of pluripotent stem cell neurodegenerative disease models","volume":"16","author":"Sandoe","year":"2013","journal-title":"Nat Neurosci"},{"key":"R77-20260525","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4155\/ppa-2017-0036","article-title":"Novel platinum compounds and nanoparticles as anticancer agents","volume":"7","author":"Sarkar","year":"2018","journal-title":"Pharm Pat Anal"},{"key":"R78-20260525","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.clnu.2013.04.007","article-title":"Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review","volume":"32","author":"Schloss","year":"2013","journal-title":"Clin Nutr"},{"key":"R79-20260525","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuro.2009.01.003","article-title":"Role of MAPKs in platinum-induced neuronal apoptosis","volume":"30","author":"Scuteri","year":"2009","journal-title":"Neurotoxicology"},{"key":"R80-20260525","first-page":"38","article-title":"A phase III randomized evaluation of amifostine in stage IIIA\/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings","volume":"29","author":"Senzer","year":"2002","journal-title":"Semin Oncol"},{"key":"R81-20260525","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"R82-20260525","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.seminoncol.2003.11.019","article-title":"Radiation Therapy Oncology Group C-0116 trial (2003) Cytoprotection\/radioprotection with amifostine: potential role in cervical cancer and early findings in the Radiation Therapy Oncology Group C-0116 trial","volume":"30","author":"Small","journal-title":"Semin Oncol"},{"key":"R83-20260525","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1305321110","article-title":"Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2","volume":"110","author":"Sprowl","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R84-20260525","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"R85-20260525","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrclinonc.2015.152","article-title":"Cancer-treatment-induced neurotoxicity--focus on newer treatments","volume":"13","author":"Stone","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"R86-20260525","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding","volume":"27","author":"Ta","year":"2006","journal-title":"Neurotoxicology"},{"key":"R87-20260525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00685326","article-title":"WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach","volume":"33","author":"Treskes","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"R88-20260525","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.29367","article-title":"PKC\/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects","volume":"137","author":"Tsubaki","year":"2015","journal-title":"Int J Cancer"},{"key":"R89-20260525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3886","article-title":"Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts","volume":"18","author":"Wainger","year":"2015","journal-title":"Nat Neurosci"},{"key":"R90-20260525","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"R91-20260525","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fct.2018.02.041","article-title":"Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation","volume":"114","author":"Wang","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"R92-20260525","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1389200219666171207121313","article-title":"Role of mitochondrial mechanism in chemotherapy-induced peripheral neuropathy","volume":"19","author":"Waseem","year":"2018","journal-title":"Curr Drug Metab"},{"key":"R93-20260525","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2005.07.966","article-title":"Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial","volume":"63","author":"Wasserman","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R94-20260525","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbi.2010.03.007","article-title":"Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic pain","volume":"24","author":"White","year":"2010","journal-title":"Brain Behav Immun"},{"key":"R95-20260525","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.scr.2017.06.006","article-title":"Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy","volume":"22","author":"Wing","year":"2017","journal-title":"Stem Cell Res"},{"key":"R96-20260525","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-15-2525","article-title":"Sustained accumulation of microtubule-binding chemotherapy drugs in the peripheral nervous system: correlations with time course and neurotoxic severity","volume":"76","author":"Wozniak","year":"2016","journal-title":"Cancer Res"},{"key":"R97-20260525","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.pain.2011.12.011","article-title":"Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin","volume":"153","author":"Xiao","year":"2012","journal-title":"Pain"},{"key":"R98-20260525","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1385\/MO:20:2:175","article-title":"Protective effect of amifostine against cisplatin-induced motor neuropathy in rat","volume":"20","author":"Yalcin","year":"2003","journal-title":"Med Oncol"},{"key":"R99-20260525","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/jnc.13355","article-title":"Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity","volume":"135","author":"Yan","year":"2015","journal-title":"J Neurochem"},{"key":"R100-20260525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","author":"Zajaczkowska","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R101-20260525","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2011.08.016","article-title":"Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy","volume":"232","author":"Zheng","year":"2011","journal-title":"Exp Neurol"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.276321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:20Z","timestamp":1786735760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.276321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":101,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.276321","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"assertion":[{"value":"2019-10-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}